Transaction Details

Footnotes

Shares withheld for tax purposes exempt under Rule 16(b)-3 in connection with the vesting of 11,578 performance stock units, the grant of which was previously reported on April 6, 2023. | Includes 250 shares of ANI Pharmaceuticals, Inc. Common Stock that were acquired under the ANI Pharmaceuticals, Inc. Employee Stock Purchase Plan in transactions that were exempt under Rule 16b-3(d) and Rule 16b-3(c). | The reporting person holds voting and dispositive power over the shares held by Esjay LLC. | The reporting person holds voting and dispositive power over the shares held by SS Pharma LLC.